Literature DB >> 29325117

Prospective Discrimination of Controllers From Progressors Early After Low-Dose Mycobacterium tuberculosis Infection of Cynomolgus Macaques using Blood RNA Signatures.

Ethan G Thompson1, Smitha Shankar1, Hannah P Gideon2, Jackie Braun1, Joe Valvo1, Jason A Skinner3, Alan Aderem1, JoAnne L Flynn2, Philana Ling Lin4, Daniel E Zak1.   

Abstract

The cynomolgus macaque model of low-dose Mycobacterium tuberculosis infection recapitulates clinical aspects of human tuberculosis pathology, but it is unknown whether the 2 systems are sufficiently similar that host-based signatures of tuberculosis will be predictive across species. By blind prediction, we demonstrate that a subset of genes comprising a human signature for tuberculosis risk is simultaneously predictive in humans and macaques and prospectively discriminates progressor from controller animals 3-6 weeks after infection. Further analysis yielded a 3-gene signature involving PRDX2 that predicts tuberculosis progression in macaques 10 days after challenge, suggesting novel pathways that define protective responses to M. tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29325117      PMCID: PMC6018950          DOI: 10.1093/infdis/jiy006

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Peroxiredoxin 1 Contributes to Host Defenses against Mycobacterium tuberculosis.

Authors:  Kazunori Matsumura; Hiroki Iwai; Masako Kato-Miyazawa; Fumiko Kirikae; Jizi Zhao; Toru Yanagawa; Tetsuro Ishii; Tohru Miyoshi-Akiyama; Keiji Funatogawa; Teruo Kirikae
Journal:  J Immunol       Date:  2016-09-07       Impact factor: 5.422

Review 2.  Understanding latent tuberculosis: a moving target.

Authors:  Philana Ling Lin; Joanne L Flynn
Journal:  J Immunol       Date:  2010-07-01       Impact factor: 5.422

3.  Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates.

Authors:  Laura E Via; P Ling Lin; Sonja M Ray; Jose Carrillo; Shannon Sedberry Allen; Seok Yong Eum; Kimberly Taylor; Edwin Klein; Ujjini Manjunatha; Jacqueline Gonzales; Eun Gae Lee; Seung Kyu Park; James A Raleigh; Sang Nae Cho; David N McMurray; JoAnne L Flynn; Clifton E Barry
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

4.  Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection.

Authors:  Saverio V Capuano; Denise A Croix; Santosh Pawar; Angelica Zinovik; Amy Myers; Philana L Lin; Stephanie Bissel; Carl Fuhrman; Edwin Klein; JoAnne L Flynn
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

5.  Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress.

Authors:  E Nagababu; J G Mohanty; J S Friedman; J M Rifkind
Journal:  Free Radic Res       Date:  2013-01-09

6.  Oxidative stress modulates heme synthesis and induces peroxiredoxin-2 as a novel cytoprotective response in β-thalassemic erythropoiesis.

Authors:  Lucia De Franceschi; Mariarita Bertoldi; Luigia De Falco; Sara Santos Franco; Luisa Ronzoni; Franco Turrini; Alessandra Colancecco; Clara Camaschella; Maria Domenica Cappellini; Achille Iolascon
Journal:  Haematologica       Date:  2011-07-12       Impact factor: 9.941

7.  Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy.

Authors:  Chloe I Bloom; Christine M Graham; Matthew P R Berry; Katalin A Wilkinson; Tolu Oni; Fotini Rozakeas; Zhaohui Xu; Jose Rossello-Urgell; Damien Chaussabel; Jacques Banchereau; Virginia Pascual; Marc Lipman; Robert J Wilkinson; Anne O'Garra
Journal:  PLoS One       Date:  2012-10-02       Impact factor: 3.240

8.  An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.

Authors:  Matthew P R Berry; Christine M Graham; Finlay W McNab; Zhaohui Xu; Susannah A A Bloch; Tolu Oni; Katalin A Wilkinson; Romain Banchereau; Jason Skinner; Robert J Wilkinson; Charles Quinn; Derek Blankenship; Ranju Dhawan; John J Cush; Asuncion Mejias; Octavio Ramilo; Onn M Kon; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Anne O'Garra
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

Review 9.  The spectrum of latent tuberculosis: rethinking the biology and intervention strategies.

Authors:  Clifton E Barry; Helena I Boshoff; Véronique Dartois; Thomas Dick; Sabine Ehrt; JoAnne Flynn; Dirk Schnappinger; Robert J Wilkinson; Douglas Young
Journal:  Nat Rev Microbiol       Date:  2009-10-26       Impact factor: 60.633

10.  PRDX2 and PRDX4 are negative regulators of hypoxia-inducible factors under conditions of prolonged hypoxia.

Authors:  Weibo Luo; Ivan Chen; Yan Chen; Duah Alkam; Yingfei Wang; Gregg L Semenza
Journal:  Oncotarget       Date:  2016-02-09
View more
  7 in total

1.  Mycobacterium tuberculosis-Induced Bronchoalveolar Lavage Gene Expression Signature in Latent Tuberculosis Infection Is Dominated by Pleiotropic Effects of CD4+ T Cell-Dependent IFN-γ Production despite the Presence of Polyfunctional T Cells within the Airways.

Authors:  Jessica Jarvela; Michelle Moyer; Patrick Leahy; Tracey Bonfield; David Fletcher; Wambura N Mkono; Htin Aung; David H Canaday; Jean-Eudes Dazard; Richard F Silver
Journal:  J Immunol       Date:  2019-09-20       Impact factor: 5.422

Review 2.  The End of the Binary Era: Revisiting the Spectrum of Tuberculosis.

Authors:  Philana Ling Lin; JoAnne L Flynn
Journal:  J Immunol       Date:  2018-11-01       Impact factor: 5.422

3.  Immune correlates of tuberculosis disease and risk translate across species.

Authors:  Mushtaq Ahmed; Shyamala Thirunavukkarasu; Bruce A Rosa; Kimberly A Thomas; Shibali Das; Javier Rangel-Moreno; Lan Lu; Smriti Mehra; Stanley Kimbung Mbandi; Larissa B Thackray; Michael S Diamond; Kenneth M Murphy; Terry Means; John Martin; Deepak Kaushal; Thomas J Scriba; Makedonka Mitreva; Shabaana A Khader
Journal:  Sci Transl Med       Date:  2020-01-29       Impact factor: 19.319

4.  Enhanced Anti-Mycobacterium tuberculosis Immunity over Time with Combined Drug and Immunotherapy Treatment.

Authors:  Sasha E Larsen; Susan L Baldwin; Mark T Orr; Valerie A Reese; Tiffany Pecor; Brian Granger; Natasha Dubois Cauwelaert; Brendan K Podell; Rhea N Coler
Journal:  Vaccines (Basel)       Date:  2018-05-24

5.  Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study.

Authors:  Adam Penn-Nicholson; Thomas Hraha; Ethan G Thompson; David Sterling; Stanley Kimbung Mbandi; Kirsten M Wall; Michelle Fisher; Sara Suliman; Smitha Shankar; Willem A Hanekom; Nebojsa Janjic; Mark Hatherill; Stefan H E Kaufmann; Jayne Sutherland; Gerhard Walzl; Mary Ann De Groote; Urs Ochsner; Daniel E Zak; Thomas J Scriba
Journal:  PLoS Med       Date:  2019-04-16       Impact factor: 11.069

6.  Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection.

Authors:  Salmaan Keshavjee; Farhana Amanullah; Adithya Cattamanchi; Richard Chaisson; Karen M Dobos; Gregory J Fox; Howard E Gendelman; Richard Gordon; Anneke Hesseling; Hoi Le Van; Beate Kampmann; Bavesh Kana; Gopal Khuller; David M Lewinsohn; Deborah A Lewinsohn; Philiana Ling Lin; Lenette Lin Lu; Gary Maartens; Andrew Owen; Marina Protopopova; Jyothi Rengarajan; Eric Rubin; Padmini Salgame; Erwin Schurr; James A Seddon; Susan Swindells; David M Tobin; Zarir Udwadia; Gerhard Walzl; Sudha Srinivasan; Roxana Rustomjee; Payam Nahid
Journal:  Am J Respir Crit Care Med       Date:  2019-03-01       Impact factor: 21.405

Review 7.  HIV and the tuberculosis "set point": how HIV impairs alveolar macrophage responses to tuberculosis and sets the stage for progressive disease.

Authors:  Sara C Auld; Bashar S Staitieh
Journal:  Retrovirology       Date:  2020-09-23       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.